SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-047287
Filing Date
2021-09-10
Accepted
2021-09-10 06:13:14
Documents
15
Period of Report
2021-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea147169-8k_inmed.htm   iXBRL 8-K 36118
2 NEWS RELEASE, DATED SEPTEMBER 9, 2021 ea147169ex99-1_inmed.htm EX-99.1 8626
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5516
  Complete submission text file 0001213900-21-047287.txt   254702

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20210909.xsd EX-101.SCH 3030
5 XBRL DEFINITION FILE inm-20210909_def.xml EX-101.DEF 26194
6 XBRL LABEL FILE inm-20210909_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE inm-20210909_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea147169-8k_inmed_htm.xml XML 3617
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211245800
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences